Preliminary results, released by the company on 2 December 2017, indicate a positive trend in treated patients versus placebo control patients, with an improvement in portal hypertension or liver biopsy.
1
—
—
Preliminary results, released by the company on 2 December 2017, indicate a positive trend in treated patients versus placebo control patients, with an improvement in portal hypertension or liver biopsy.